Chlamydia Prevalence and Testing Project - a randomised controlled trial

Chlamydia prevalence and testing program targetting women aged 16 to 24 years in general practice

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12608000499381

Acronym

CLASP

Enrollment

Registered

2008-09-30

Start date

2008-05-15

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

To determine whether a $5 incentive payment will lead to increased chlamydia testing rates by general practitioners.

Interventions

The randomisation unit is general practitioner (GP) clinic. Intervention group: GPs will receive $5 reimbursement for each eligible women aged 16 to 24 years screened for chlamydia each year. The intervention will be in place for 6 months. GPs will be expected to conduct chlamydia screening during a routine consultation with an eligible patient. Screening involves requesting a chlamydia test for the patient. It should take a couple of minutes to discuss with the patient during the consultation

Study design

Allocation

Randomised controlled trial

Intervention model

Parallel

Primary purpose

Prevention

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

>250 women aged 16-24 years attending the GP clinic in the past year. Minimum of 2 full time equivalent (EFT) GPs per clinic. An electronic medical records database.

Exclusion criteria

Clinics will be excluded from the project if they do not see more than 250 women aged 16 to 24 years per year.

Outcome results